313 related articles for article (PubMed ID: 34217413)
1. Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.
Walker MJ; Meggetto O; Gao J; Espino-Hernández G; Jembere N; Bravo CA; Rey M; Aslam U; Sheppard AJ; Lofters AK; Tammemägi MC; Tinmouth J; Kupets R; Chiarelli AM; Rabeneck L
Prev Med; 2021 Oct; 151():106586. PubMed ID: 34217413
[TBL] [Abstract][Full Text] [Related]
2. The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study.
Meggetto O; Jembere N; Gao J; Walker MJ; Rey M; Rabeneck L; Murphy KJ; Kupets R;
BJOG; 2021 Aug; 128(9):1503-1510. PubMed ID: 33982870
[TBL] [Abstract][Full Text] [Related]
3. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
[TBL] [Abstract][Full Text] [Related]
4. Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals.
El-Zein M; Ali R; Farah E; Botting-Provost S; Franco EL;
Elife; 2023 Jun; 12():. PubMed ID: 37377399
[TBL] [Abstract][Full Text] [Related]
5. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
[TBL] [Abstract][Full Text] [Related]
6. Cervical screening during the COVID-19 pandemic: optimising recovery strategies.
Castanon A; Rebolj M; Burger EA; de Kok IMCM; Smith MA; Hanley SJB; Carozzi FM; Peacock S; O'Mahony JF
Lancet Public Health; 2021 Jul; 6(7):e522-e527. PubMed ID: 33939965
[TBL] [Abstract][Full Text] [Related]
7. Delivery of Cancer Care in Ontario, Canada, During the First Year of the COVID-19 Pandemic.
Walker MJ; Wang J; Mazuryk J; Skinner SM; Meggetto O; Ashu E; Habbous S; Nazeri Rad N; Espino-Hernández G; Wood R; Chaudhry M; Vahid S; Gao J; Gallo-Hershberg D; Gutierrez E; Zanchetta C; Langer D; Zwicker V; Rey M; Tammemägi MC; Tinmouth J; Kupets R; Chiarelli AM; Singh S; Warde P; Forbes L; Dobranowski J; Irish J; Rabeneck L;
JAMA Netw Open; 2022 Apr; 5(4):e228855. PubMed ID: 35467731
[TBL] [Abstract][Full Text] [Related]
8. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
[TBL] [Abstract][Full Text] [Related]
9. Le disuguaglianze di accesso ai programmi di screening dei tumori della mammella, del colon retto e della cervice uterina sono aumentate durante il periodo pandemico. Risultati di un health equity audit condotto dall'Agenzia di Tutela della Salute d.
Girardi D; Vecchio R; Tanious M; Cacitti S; Ancarani C; Dalle Carbonare S; Perotti P; Bonafede C; Cavallo R; Gentile L; Parrini A; Lucente EM; Carlesso A; Cadum E; Cecconami L; Odone A; Deandrea S
Epidemiol Prev; 2024; 48(2):130-139. PubMed ID: 38770730
[TBL] [Abstract][Full Text] [Related]
10. Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities.
Wentzensen N; Clarke MA; Perkins RB
Prev Med; 2021 Oct; 151():106596. PubMed ID: 34217415
[TBL] [Abstract][Full Text] [Related]
11. Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada.
Malagón T; Yong JHE; Tope P; Miller WH; Franco EL;
Int J Cancer; 2022 Apr; 150(8):1244-1254. PubMed ID: 34843106
[TBL] [Abstract][Full Text] [Related]
12. Understanding COVID-19 impact on cervical, breast, and colorectal cancer screening among federally qualified healthcare centers participating in "Back on track with screening" quality improvement projects.
Fisher-Borne M; Isher-Witt J; Comstock S; Perkins RB
Prev Med; 2021 Oct; 151():106681. PubMed ID: 34217422
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
14. The Use of Cremation Data for Timely Mortality Surveillance During the COVID-19 Pandemic in Ontario, Canada: Validation Study.
Postill G; Murray R; Wilton AS; Wells RA; Sirbu R; Daley MJ; Rosella L
JMIR Public Health Surveill; 2022 Feb; 8(2):e32426. PubMed ID: 35038302
[TBL] [Abstract][Full Text] [Related]
15. Adherence to guidance for prioritizing higher risk groups for breast cancer screening during the COVID-19 pandemic in the Ontario Breast Screening Program: a descriptive study.
Chiarelli AM; Walker MJ; Espino-Hernandez G; Gray N; Salleh A; Adhihetty C; Gao J; Fienberg S; Rey MA; Rabeneck L
CMAJ Open; 2021; 9(4):E1205-E1212. PubMed ID: 34933878
[TBL] [Abstract][Full Text] [Related]
16. Cross-sectional survey of the impact of the COVID-19 pandemic on cancer screening programs in selected low- and middle-income countries: Study from the IARC COVID-19 impact study group.
Villain P; Carvalho AL; Lucas E; Mosquera I; Zhang L; Muwonge R; Selmouni F; Sauvaget C; Basu P;
Int J Cancer; 2021 Jul; 149(1):97-107. PubMed ID: 33533501
[TBL] [Abstract][Full Text] [Related]
17. Canadian Landscape Assessment of Colorectal Cancer Screening during the COVID-19 Pandemic.
El Bizri M; Hamidi MW; Mksyartinian P; Stein BD
Curr Oncol; 2023 Oct; 30(10):8973-8991. PubMed ID: 37887548
[TBL] [Abstract][Full Text] [Related]
18. The Short-Term Impact Of COVID-19 Pandemic on Cervical Cancer Screening: A Systematic Review and Meta-Analysis.
Sasidharanpillai S; Ravishankar N
Asian Pac J Cancer Prev; 2022 May; 23(5):1497-1504. PubMed ID: 35633530
[TBL] [Abstract][Full Text] [Related]
19. Using geographic methods to inform cancer screening interventions for South Asians in Ontario, Canada.
Lofters AK; Gozdyra P; Lobb R
BMC Public Health; 2013 Apr; 13():395. PubMed ID: 23622426
[TBL] [Abstract][Full Text] [Related]
20. Understanding those overdue for cancer screening by five years or more: A retrospective cohort study in Ontario, Canada.
Lofters AK; Kopp A; Vahabi M; Glazier RH
Prev Med; 2019 Dec; 129():105816. PubMed ID: 31445111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
